People / Staff

Arielle Kane

Arielle Kane is the director of health care at PPI. Her research focuses on what comes next for health policy in order to expand access, reduce costs and improve quality. Specifically, she focusses on how innovation in health care can help meet the goals of the triple aim. Prior to joining PPI, she worked at the Deloitte Center for Health Solutions where she researched provider issues, including conducting a survey of health system CEOs on the future of health care; policy issues, including analysis of the recent tax overhaul; and managed a weekly newsletter which provided updates and analysis on health policy and industry news. Arielle also worked in Oregon politics prior to moving to Washington, DC. Arielle received her Master of Public Policy from Georgetown University. She lives in Washington, DC with her bulldog, Hank.

Writings

Other

By / 3.26.2019

On the campaign trail, Donald Trump promised no cuts to Medicaid, that he would protect those with preexisting conditions, and that everyone would have insurance under his new health care plan. He has broken every one of those promises over the last two years. What’s more, the White House campaign to sabotage the Affordable Care […]

Other

By / 3.19.2019

A bill working its way through the Minnesota state legislature would prohibit drugmakers from “price gouging” for essential prescription drugs. The law seeks to end some pretty egregious behavior by bad actors in the biopharmaceutical industry. Like any industry, the drug industry has its share of bad actors. The loathsome “pharma bro” Martin Shkreli is […]

Publications

By / 3.1.2019

In searching for ways to satisfy public demand for lower drug prices, President Trump has found rare common ground with Democrats. The White House recently released a plan to reform the way pharmacy benefit managers (PBMs) negotiate prices with drugmakers on behalf of health insurance companies. Specifically, the proposal takes aim at special discounts or […]

Publications

By / 2.14.2019

America’s massive health care industry faces three major challenges: how to cover everyone, reduce costs, and increase productivity. Telehealth – the use of technology to help treat patients remotely – may help address all three. Telehealth reduces the need for expensive real estate and enables providers to better leverage their current medical personnel to provide […]

Blog

By / 2.8.2019

Washington has long been a leader in both innovation and health care. Telehealth, which lays at the intersection of the two, is an innovative, cost-effective way to deliver health care to underserved populations. Seeing the value of telehealth, Washington State requires health insurance companies, Medicaid managed care plans, and health plans offered to Washington State employees to […]

Other

By / 1.25.2019

Despite a strong economy and low unemployment, the number of Americans who lack health insurance is rising. The uninsured rate among adults in the fourth quarter of 2018 climbed to 13.7 percent, well above the low point of 10.9 percent in 2016, according to Gallup’s National Health and Well-Being Index. That means 7 million Americans […]

Op-eds and Articles

By / 12.19.2018

Republicans love to complain about “activist judges,” that is, until they find one willing to do their political bidding. On Friday, members of the GOP hailed a ruling by U.S. District Judge Reed O’Connor striking down the Affordable Care Act (ACA) as unconstitutional. They didn’t seem to care that O’Connor had to use some highly […]

Blog

By / 11.19.2018

Health care costs continue to be top of mind for a plurality of voters, according to a recent poll by PPI and Expedition Strategies. Our poll surveyed 1,090 likely voters on to gather data to apply context and to for what kind of agenda progressives should craft as the 2020 election cycle dawns. Health care […]

Publications

By / 10.24.2018

“Millions of our citizens do not now have a full measure of opportunity to achieve and enjoy good health. Millions do not now have protection or security against the economic effects of sickness. The time has arrived for action to help them attain that opportunity and that protection.” –President Harry Truman, 1945

Publications

By / 10.3.2018

Carl Icahn, the billionaire businessman and investor, recently advised shareholders to reject Cigna’s proposed $67 billion acquisition of the pharmacy benefit manager (PBM) Express Scripts. He says that a reckoning is coming for PBMs and that the price grossly exaggerated their value as “over-earning middle men.” In 2016, PBMs made $23 billion in gross profits […]